Skip to main content
The Actuary: The magazine of the Institute and Faculty of Actuaries - return to the homepage Logo of The Actuary website
  • Search
  • Visit The Actuary Magazine on Facebook
  • Visit The Actuary Magazine on LinkedIn
  • Visit @TheActuaryMag on Twitter
Visit the website of the Institute and Faculty of Actuaries Logo of the Institute and Faculty of Actuaries

Main navigation

  • News
  • Features
    • General Features
    • Interviews
    • Students
    • Opinion
  • Topics
  • Knowledge
    • Business Skills
    • Careers
    • Events
    • Predictions by The Actuary
    • Whitepapers
    • Moody's - Climate Risk Insurers series
    • Webinars
    • Podcasts
  • Jobs
  • IFoA
    • CEO Comment
    • IFoA News
    • People & Social News
    • President Comment
  • Archive
Quick links:
  • Home
  • The Actuary Issues
  • October 2021
General Features

As the smoke clears

Open-access content Wednesday 6th October 2021
Authors
David Lu is Asia
Wendy Wang

David Lu and Wendy Wang investigate the increasing global incidence of lung cancer among women who have never smoked

web-p28-30--Siloutte-of-woman-shrouded-in-smoke--Getty--682304899.jpg

In the past, lung cancer was considered a predominantly male cancer due to its associations with smoking – according to the World Health Organization, around 40% of men smoke, compared to about 9% of women. While anti-smoking campaigns and legislation have successfully reduced lung cancer incidence, evidence is emerging that one subtype of lung cancer, adenocarcinoma (ADC), is on the rise in women who have never smoked.

At the same time, the introduction of low-dose computerised tomography (LDCT) screening for lung cancer in 2011 has increased the detection of less aggressive and earlier stage cancers.

In recent years, we have seen increases in critical illness claims from women with lung cancer in some Asian markets, where products pay upon cancer diagnosis. What do we know about the epidemiological and histological features of this type of lung cancer, and how might it impact underwriting, pricing and product design for life and health insurers?

Lung cancer in young women

According to US data covering 1995-2014, age-specific incidence of lung cancer has generally decreased among both men and women aged 30-54 – but the decline has been steeper for men. Among those born after the mid-1960s, incidence rates of lung cancer are significantly higher among young women than among young men. This crossover cannot be fully explained by sex differences in smoking behaviours.

A systematic analysis in 40 countries across five continents found that the female-to-male incidence rate ratios of lung cancer in recent-born cohorts are significantly greater in Canada, Denmark, Germany, New Zealand, the Netherlands and the US. Similar patterns, though non-significant, were found in 23 additional countries. These crossovers were largely driven by increasing incidence rates of the ADC subtype in women.

 

Figure 1
Figure 1: Relative frequency of major subtypes of lung cancer in Chinese women, by year of diagnosis.

 

The rise of female ADC

Histologically, lung cancer is divided into four major subtypes: squamous cell carcinoma (SCC), ADC, large cell lung cancer and small cell lung cancer. The first three subtypes are collectively referred to as non-small cell lung cancer, and account for 90% of lung cancer cases.

Multiple studies have shown that ADC is the most common subtype of lung cancer in people who have never smoked, and this is consistent with the fact that more than half of global female lung cancer patients have never smoked; in Asia, this figure is 60-80%. The effect of smoking cessation on reducing ADC in women is much lower than for other types of lung cancer.

Smoking is still the number one cause of lung cancer. However, with the success of anti-smoking campaigns and legislation, the problem of lung cancer among non-smokers – especially ADC in women – will become more prominent. In view of its distinct carcinogenic factors, biological characteristics, treatment and prognosis, ADC should be treated differently from lung cancer caused by smoking.

Research from China has shown that the relative frequencies of the different lung cancer subtypes (in other words,the proportion of lung cancer cases represented by each subtype) developed very differently for men and women during the 2000s (Figure 1 and Figure 2).In particular, ADC stands out as the increasingly dominant cancer subtype for females.

Consistently with this, a US study has shown that, although overall lung cancer incidence has gradually declined since 1992, ADC incidence has increased from 8.9 cases per 100,000 people in 1973 to 20.3 in 2015. For women, this increase was from 5.4 cases per 100,000 people to 19.5. In 1985, ADC surpassed SCC to become the most common subtype of lung cancer, and its incidence continues to increase.

The significant increase of ADC in women, seen in different parts of the world, cannot be conclusively explained by conventional risk factors such as smoking, air pollution or diet. Its true cause will need to be further and fully investigated.

 

Figure 2
Figure 2: Relative frequency of major subtypes of lung cancer in Chinese men, by year of diagnosis.

 

LDCT screening

LDCT uses a low dose of radiation to make detailed images of lungs. In 2011, the US’s National Lung Screening Trial (NLST) team found that, among high-risk populations, lung cancer screening conducted via LDCT led to a 20% decrease in mortality compared to screening using chest X-ray, and this opened the door to the use of LDCT for lung cancer screening. The report also showed that the number of lung cancer cases detected by LDCT was 12.6% higher than for the X-ray group.

A study in Shanghai found that since the introduction of LDCT screening the incidence of female lung cancer has increased significantly. Incidence in Shanghai’s central Xuhui District, where two top hospitals provide LDCT screening, saw an annual increase of 19.8% between 2011 and 2014, compared to an average of 1.1% per year between 2005 and 2011.The increase was mainly in the younger age groups.

The volume-doubling time of tumours reflects their growth rate, and is a key indicator of their aggressiveness. The longer the doubling time, the slower the tumour growth rate.

Among the four lung cancer subtypes, ADC grows the slowest. Multiple studies have shown that the average volume-doubling time of ADC detected by LDCT is 400-800 days – far longer than that of ADC detected by chest X-ray, which is 110-220 days. In other words, LDCT enables much less aggressive cases of ADC to be detected. The average volume-doubling times of SCC detected by the two screening methods do not significantly differ.

LDCT is also able to detect more early-stage cancers, particularly stage 1 cancers, than chest X-ray. This materially improves lung cancer prognosis due to the higher survival rates associated with stage 1 lung cancer (for example, the five-year survival rate of T1a cancer is as high as 92%).

“With the success of anti-smoking campaigns, the problem of lung cancer among non-smokers will become more prominent”

Insurance industry impacts

The ADC increase among women who have never smoked, combined with LDCT screening, is changing the face of lung cancer claims in critical illness products. Some insurers have already seen an increase in young female claimants. While early diagnosis has a proven link to better survival, some of these diagnoses may not have become claims in the past – thus leading to increased claims now.

The exact balance between early and additional diagnosis is unknown. In other words, it is unclear how much of the increase in lung cancer claims is earlier or accelerated claims, as opposed to additional claims for insurers. This could also depend on the coverage term of the underlying product. For example, earlier diagnosis and claim could be the more prominent effect behind increased incidence on whole-of-life accelerated critical illness products, while additional claim has more of an effect on short-term critical illness products.

What is clear is that lung cancer in women who have never smoked has distinct epidemiological and biological features and risk factors compared to the more aggressive lung cancers seen in male smokers, and should therefore be treated differently. While there is more to be investigated here, the following should be considered:

  • Experience monitoring: Policyholders are generally becoming more health-aware, with a higher propensity to access cancer screening, so potential impacts from insured behaviours cannot be ignored. Insurers could pay more attention to the potential rising trend in lung cancer claims, especially among women and higher sum-assureds, and any potential divergence between the experiences of the insured and the general population.

  • Pricing: Future lung cancer trends depend heavily on behavioural factors such as screening activity, and it is difficult to predict how long these trends will last. The impacts of screening observed so far may be a starting point for understanding potential future trends, and China’s critical illness claims experience may be a useful reference for markets where LDCT is just emerging. Beside screening, the epidemiological drivers for rising ADC in females remains unclear, leaving further pricing uncertainty.

  • Underwriting: The application of LDCT in screening can find more lung cancers, as well as more pulmonary nodules. Proper underwriting on the risk of pulmonary nodules in people who have never smoked should be considered.

  • Product design: The insurance industry may need to collect more incidence and prognosis data, and reconsider the benefits of diagnosis in cases that are at risk of over-diagnosis. Generally, the insured benefit should be commensurate with the economic loss suffered in an insured event. Product designs that encourage adverse selection should be avoided.

Table 1
Table 1: Average annual % change of lung cancer incidence rate in Xuhui District among men and women from 2005-2014, stratified by age at diagnosis.

A full bibliography can be found with the online version of this article at bit.ly/3AtqVu6

Dr David Lu is Asia chief medical officer at Swiss Re

Wendy Wang is head of pricing innovation, Life & Health China at Swiss Re

Image credit | Getty

Linked ACT Oct21_Full LR.jpg
This article appeared in our October 2021 issue of The Actuary .
Click here to view this issue

You may also be interested in...

web-p31-33-EHRs-oct-cover-feature.jpg

The patient data pipeline

Niall Fennelly sets out key lessons around electronic health records for insurance, and explores what the future could hold
Wednesday 6th October 2021
Open-access content
web-p38-41-parametric_shutterstock_223598188.jpg

Boxing clever: novel thinking behind parametric products

Alin Radu, Laurent Sabatié and Davide De Santis discuss insurers’ use of novel data sources and structures to create innovative parametric products
Wednesday 6th October 2021
Open-access content
web-p16-18-Biodiversity-©Shutterstock-Sarah-Auld-.jpg

Fall of the wild?

Gillian Rutherford-Liske and Samantha Dunn explain the role general insurers can play in tackling extreme weather and ecosystem loss
Wednesday 6th October 2021
Open-access content
web-p34-35-climate-health_melting-planet-.jpg

Unhealthy planet, unhealthy people

Richard Purcell and Anna Spender present a selection of experts’ opinions on how climate change could affect health, care and protection, drawn from a recent IFoA Health and Care webinar
Wednesday 6th October 2021
Open-access content
q

A fairer deal for diabetes

The insurance industry needs to update its understanding of diabetes, say Nicola Oliver and Scott Reid
Wednesday 3rd November 2021
Open-access content
web-p24-27-Indepth--Stack-of-Toy-cars--Getty--82862527.jpg

A better fit: presenting an intuitive and flexible non-linear regression model

Andrei Badescu, Tsz Chai Fung, X Sheldon Lin and Spark Tseung present a flexible nonlinear regression model and software for insurance risk classification, ratemaking and reserving
Wednesday 6th October 2021
Open-access content

Latest from Health care

yf

Animal crossing: the threat of zoonotic diseases

Prachi Patkee and Adam Strange discuss what the rising threat of climate-driven communicable disease means for insurers
Wednesday 30th November 2022
Open-access content
hb

Boiling point: the effect of rising temperatures on future mortality

As quantifying climate risk exposure becomes increasingly important, Dan Gill, Rajinder Poonian and Alex Harding investigate the effect of rising temperatures on future mortality
Wednesday 2nd November 2022
Open-access content
vb

Interview: Professor Paul Dalziel on changing the focus of economies from growth to wellbeing

Paul Dalziel talks to Alex Martin about the true purpose of economics and the lessons we can draw from the 2019 New Zealand wellbeing budget
Wednesday 2nd November 2022
Open-access content

Latest from General Insurance

td

Brain power

The latest microchips mimic cerebral function. Smaller, faster and more efficient than their predecessors, they have the potential to save lives and help insurers, argues Amarnath Suggu
Wednesday 1st March 2023
Open-access content
bl

'Takaful' models of Islamic insurance

Ethical, varied and a growing market – ‘takaful’ Islamic insurance is worth knowing about, wherever you’re from and whatever your beliefs, says Ali Asghar Bhuriwala
Wednesday 1st February 2023
Open-access content
il

When 'human' isn't female

It was only last year that the first anatomically correct female crash test dummy was created. With so much data still based on the male perspective, are we truly meeting all consumer needs? Adél Drew discusses her thoughts, based on the book Invisible Women by Caroline Criado Perez
Wednesday 1st February 2023
Open-access content

Latest from General Features

yguk

Is anybody out there?

There’s no point speaking if no one hears you. Effective communication starts with silence – this is the understated art of listening, says Tan Suee Chieh
Thursday 2nd March 2023
Open-access content
ers

By halves

Reducing the pensions gap between men and women is a work in progress – and there’s still a long way to go, with women retiring on 50% less than men, says Alexandra Miles
Thursday 2nd March 2023
Open-access content
web_Question-mark-lightbulbs_credit_iStock-1348235111.png

Figuring it out

Psychologist Wendy Johnson recalls how qualifying as an actuary and running her own consultancy in the US allowed her to overcome shyness and gave her essential skills for life
Wednesday 1st March 2023
Open-access content

Latest from Data Science

gc

Free for all

Coding: those who love it can benefit those who don’t by creating open-source tools. Yiannis Parizas outlines two popular data science programming languages, and the simulator he devised and shared
Wednesday 1st March 2023
Open-access content
il

When 'human' isn't female

It was only last year that the first anatomically correct female crash test dummy was created. With so much data still based on the male perspective, are we truly meeting all consumer needs? Adél Drew discusses her thoughts, based on the book Invisible Women by Caroline Criado Perez
Wednesday 1st February 2023
Open-access content
res

Interview: Tim Harford on the importance of questioning our assumptions

Tim Harford speaks to Ruolin Wang about why it’s so important to slow down and question things from emotive headlines to the numbers and algorithms we use in our work
Wednesday 30th November 2022
Open-access content

Latest from October 2021

web-p42-43-People-and-society_IMG_1688.jpg

People and society news: October

People and society news: October
Wednesday 6th October 2021
Open-access content
Puzzles-iStock-1146577830.jpg

Puzzles October 2021

Puzzles October 2021
Wednesday 6th October 2021
Open-access content
web-p45-student_student_oct-(1).jpg

Full steam ahead: insurers and product innovation

Ciara Izuchukwu looks at how insurers are innovating to provide more personalised products to customers – and why this is so important
Wednesday 6th October 2021
Open-access content
Share
  • Twitter
  • Facebook
  • Linked in
  • Mail
  • Print

Latest Jobs

Actuarial Manager - Non-Life Reserving

London (Central)
£ excellent package
Reference
148614

Senior Reinsurance Pricing Actuary

London, England
£130000 - £155000 per annum
Reference
148611

Capital Analytics Manager

London, England
£80000 - £120000 per annum
Reference
148610
See all jobs »
 
 
 
 

Sign up to our newsletter

News, jobs and updates

Sign up

Subscribe to The Actuary

Receive the print edition straight to your door

Subscribe
Spread-iPad-slantB-june.png

Topics

  • Data Science
  • Investment
  • Risk & ERM
  • Pensions
  • Environment
  • Soft skills
  • General Insurance
  • Regulation Standards
  • Health care
  • Technology
  • Reinsurance
  • Global
  • Life insurance
​
FOLLOW US
The Actuary on LinkedIn
@TheActuaryMag on Twitter
Facebook: The Actuary Magazine
CONTACT US
The Actuary
Tel: (+44) 020 7880 6200
​

IFoA

About IFoA
Become an actuary
IFoA Events
About membership

Information

Privacy Policy
Terms & Conditions
Cookie Policy
Think Green

Get in touch

Contact us
Advertise with us
Subscribe to The Actuary Magazine
Contribute

The Actuary Jobs

Actuarial job search
Pensions jobs
General insurance jobs
Solvency II jobs

© 2023 The Actuary. The Actuary is published on behalf of the Institute and Faculty of Actuaries by Redactive Publishing Limited. All rights reserved. Reproduction of any part is not allowed without written permission.

Redactive Media Group Ltd, 71-75 Shelton Street, London WC2H 9JQ